Skip to main content
Igor Espinoza-Delgado, MD, Oncology, Baltimore, MD

IgorJEspinoza-DelgadoMD

Oncology • Baltimore, MD

Physician

Join to view full profile

Are you Dr. Espinoza-Delgado?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 16 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    3001 S Hanover St
    Nia-Astra Unit, 5th Floor
    Baltimore, MD 21225
    Phone+1 410-350-7317
    Fax+1 410-350-3979
  • Is this information wrong?

Summary

  • Dr. Igor Espinoza-Delgado, MD is an oncologist in Baltimore, Maryland.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
  • Central University of Venezuela
    Central University of VenezuelaClass of 1980

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Antitumor And Immunomodulatory Activities Of Bryostatin-National Institute On Aging2005
  • Phase II Trial Of Bryostatin-1 And Rituximab In B CellNational Institute On Aging2004–2005
  • Aging, Cancer, And The Immune SystemNational Institute On Aging2003–2005
  • Antitumor And Immunomodulation: Bryostatin-1/Il-2National Institute On Aging2004
  • Phase 2 Trial Of Bryostatin-1/Rituximab In B Cell CancerNational Institute On Aging2003
  • Antitumor/Immunomodulatory Activities--Bryostatin-1/Il2National Institute On Aging2003
  • Bryostatin-1 And IL-2 In Monocytes As APCNational Center For Research Resources2000–2001
  • Trial Of Bryostatin/Il-2 To Enhance Antigen PresentationNational Cancer Institute1999

Dr. Igor Espinoza-Delgado, Dr. Igor Espinoza-Delgado, MD, Dr. I Espinoza-Delgado, Dr. Igor J Espinoza-Delgado